PETA ANTIBIOTIKA RSUD BANGIL SEMESTER II 2018

NO. JENIS ANTIBIOTIKA SENSITIVE INTERMEDIATE RESISTEN

1 Amikacin 46 13 43
2 Ampicillin 6 2 9
3 Ampicillin/Sulbactam 7 4 10
4 Azithromycin 9 1 26
5 Aztreonam 20 4 30
6 Cefazolin 1 1 14
7 Cefepime 47 9 45
8 Cefoperazone/Sulbactam 11 4 11
9 Cefoxitin 6 0 19
10 Ceftazidime 50 53 16
11 Ceftriaxone 22 15 59
12 Cefuroxime 2 4 10
13 Chloramphenicol 26 11 61
14 Ciprofloxacin 37 16 42
15 Clindamycin 2 1 8
16 Colistin 8 0 3
17 Erythromycin 5 1 5
18 Gatifloxacin 8 0 3
19 Gentamycin 48 8 54
20 Levofloxacin 56 6 58
21 Linezolid 5 0 6
22 Lomefloxacin 7 0 3
23 Meropenem 71 9 33
24 Minocycline 53 16 54
25 Moxifloxacin 7 0 3
26 Norfloxacin 7 0 3
27 Ofloxacin 32 12 36
28 Oxacillin 2 0 8
29 Penicillin 1 0 10
30 Piperacillin 36 14 35
31 Piperacillin/Tazobactam 65 12 23
32 Rifampicin 3 2 5
33 Tetracycline 3 1 6
34 Ticarcillin 0 0 1
35 Ticarcillin/Clavulanate 37 16 47
36 Tobramycin 28 8 48
37 Trimethoprim-Sulfamethoxazole 41 0 82
38 Vancomycin 5 1 5
GRAFIK PETA ANTIBIOTIKA RSUD BANGIL SEMESTER II 2018

100%

90%

80%

70%

60%

50%

40%
Resisten
30% Intermediate
Sensitive

20%

10%

0%
l
cin llin tam cin am olin ime tam itin ime one ime ico cin cin stin cin cin cin cin olid cin em line cin cin cin illin illin illin tam icin line illin ate cin ole cin
ika pici bac omy eon faz fep bac fox zid iax rox hen oxa amy Coli omy oxa amy oxa nez oxa pen cyc oxa oxa oxa xac nic rac bac mp cyc arc ulan amy xaz omy
Am Am Sul ithr ztr Ce Ce Sul Ce efta eftr efu mp rofl lind r fl t fl i fl o o ifl fl fl e e a a ic
th Gati Gen evo L me er Min ox Nor O O P Pip Tazo Rif Tetr T Clav Tob eth Van
r o c
n / z A e/ C C C r a i p C r y L o M M / / m
li A on o C E L
icil az Chl ci llin cillin ulfa
p er ra ar -S
Am fop ipe Tic r im
p
Ce P
ho
et
im
Tr